S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer

NCT00103324 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Diffuse Adenocarcinoma of the Stomach
Intestinal Adenocarcinoma of the Stomach
Mixed Adenocarcinoma of the Stomach
Recurrent Gastric Cancer
Stage III Gastric Cancer
Stage IV Gastric Cancer

Interventions

DRUG: lapatinib ditosylate
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)